EPHA1 and cancer: The drug delivery systemcombines the advantages of a therapeutic agent with two differentmechanisms to ensure that it is used efficiently for cancer therapy.In this study, a nanostructured lipid carrier system was prepared,Docetaxel was loaded to these systems, and the Eph siRNA was adsorbedto the outer surface.